MS Speaks
Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on December 19, 2019, 08:05:04 pm
-
From PubMed (December 19, 2019)--"High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice":
https://www.ncbi.nlm.nih.gov/pubmed/31845825
-
An update on high-dose biotin from Business Wire (March 10, 2020):
https://www.businesswire.com/news/home/20200310005779/en/MedDay-Reports-Top-Line-Data-Phase-III-Trial